Serena Jingchuan Guo, M.D., Ph.D., an assistant professor of pharmaceutical outcomes and policy in the UF College of Pharmacy and the studys senior author, said this research carries significant implications for older patients with diabetes, a group that has a higher depression risk than the general population
IcoSema is a once-weekly combination therapy of basal insulin icodec and semaglutide designed to improve glycaemic control with reduced injection frequency
Some of the stem cell-derived therapies have only been studied in clinical trial settings and have been used in Parkinsons and other neurodegenerative diseases
While the effects of accidental intravenous injection are not well-documented, it is prudent to err on the side of caution
In December, the Therapeutic Goods Administration (TGA) granted approval for Wegovy to be used as a complementary therapy for adults with both cardiovascular disease and high body mass index to reduce the related heart attack, stroke or death risks
doi:10.1093/gerona/glad038